Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 12, 2002, Pages 1299-1306

  Dong, Yuhong ^a   Xi, Hongli ^a   Yu, Yanyan ^a   Wang, Qinhuan ^a   Jiang, Kan ^b   Li, Liuzhe ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antiviral drug; Hepatitis B virus S gene; Immune response; Oxymatrine; T helper cell 1 and 2 cytokine; Transgenic mouse

Indexed keywords

DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; OXYMATRINE; VITRONECTIN;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS B VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

EID: 0036435794     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02885.x     Document Type: Article

References (28)

1. Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J. Gastroenterol. Hepatol. 2000; 15(Suppl.); E67-70.
2. Chen X, Wang G, Cai X, Yu H, Hu Y. Oxymatrine down-regulates HBV gene expression in HBV transgenic mice. J. Sec. Milit. Med. Uni. 1999; 20: 746-8.
3. Lu H, Wang Q, Zeng Z et al. In vitro study on the effect and mechanism of different forms of oxymatrine on HBV. Inform. Infect. Dis. 2001; 14 (Suppl.): 10-11.
4. Huang S, Liu X, Yang Y et al. The pharmacokinetics of oxymatrine in rabbits. Chin. Tradit. Herbal Drugs 1987; 18 (9): 18-19.
5. Yu Y, Si C, Zeng Z et al. The clinical trial of oxymatrine on chronic viral hepatitis type B. Chin. J. Intern. Med. 2002; 40: 843-6.
6. Li J, Li C, Zeng M et al. Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C. Chin. J. Mod. Dev. Tradit. Med. 1998; 18: 227-9.
7. Huang X, Li B, Shen L, Wang J. Inhibitory effects of four alkaloids of Sophora alopecuroides on TNF-α production by murine peritoneal macrophages. Pharmacol. Clin. Remedies Chin. Tradit. Drugs 2001; 17 (3): 12-14.
8. Wang H, Zhang L, Du S, Qian Y. Effects of Oxymatrine on the proliferation of lymphocytes. Chin. Tradit. Herbal Drugs 1994; 25 (7): 362-3.
9. Chisari FV, Pinkert CA, Milich DR et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985; 230: 1157-60.
10. Babinet C, Farza H, Morello D, Hadchouel M. Pourcel+ C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 1985; 230: 1160-3.
11. Takashima H, Araki K, Miyazaki J, Yamamura K, Kimoto M. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice. Immunology 1992; 75: 398-405.
12. Liu G, Jia Y, Wang H, Xiong Y, Tong M. Immunological function of T cell from HBV transgenic mice. Chin. J. Vet. Sci. 2000; 20 (4): 356-7.
13. Chisari FV, Filippi P, McLachlan A et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 1986; 60: 880-7.
14. Cheng G, He Y, Zhou X. Fluorescence quantitative PCR and its application in detection of hepatitis B virus. Chin. J. Med. Lab. Sci. 1999; 22 (3): 135-8.
15. Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995; 21: 620-6.
16. Chisari FV. Hepatitis B virus transgenic mice: Insights into the virus and the disease. Hepatology 1995; 22: 1316-25.
17. Muraillle E, Leo O. Revisiting the Th1/Th2 paradigm. Scand. J. Immunol. 1998; 47: 1-9.
18. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-51.
19. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T-cell derived cytokines. Annu. Rev. Immunol. 1992; 10: 385-409.
20. Maggi E, Mazzetti M, Ravina A et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265: 244-8.
21. Penna A, Prete GD, Cavalli A et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25: 1022-7.
22. Bertoletti A, Delios MM, Boni C et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112: 193-9.
23. Martin J, Navas S, Quiroga JA et al. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine 1998; 10: 635-44.
24. Cramp ME, Rossol S, Chokshi S et al. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000; 118: 346-55.
25. Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J. Gen. Virol. 1998; 79: 2381-91.
26. Rico MA, Quiroga JA, Subira D et al. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alfa. Hepatology 2001;33: 295-30.
27. Ning Q, Brown D, Parodo J et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 1998; 160: 3487-93.
28. Tam RC, Pai B, Bard J et al. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J. Hepatol. 1999; 30: 376-82.